2,3-dihydro-1,4-benzothiazine and Parkinson Disease

2,3-dihydro-1,4-benzothiazine has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dryhurst, G; Shen, XM	1

Other Studies

1 other study(ies) available for 2,3-dihydro-1,4-benzothiazine and Parkinson Disease

Article	Year
Further insights into the influence of L-cysteine on the oxidation chemistry of dopamine: reaction pathways of potential relevance to Parkinson's disease. Chemical research in toxicology, 1996, Volume: 9, Issue:4 Topics: Animals; Antineoplastic Agents; Brain; Chromatography, High Pressure Liquid; Cysteine; Cysteinyldopa; Dopamine; Electrochemistry; Electrodes; Injections, Intravenous; Lethal Dose 50; Mice; No-Observed-Adverse-Effect Level; Osmolar Concentration; Oxidation-Reduction; Parkinson Disease; Spectrophotometry, Ultraviolet; Thiazines	1996

Article

Year

Further insights into the influence of L-cysteine on the oxidation chemistry of dopamine: reaction pathways of potential relevance to Parkinson's disease.

Chemical research in toxicology, 1996, Volume: 9, Issue:4

Topics: Animals; Antineoplastic Agents; Brain; Chromatography, High Pressure Liquid; Cysteine; Cysteinyldopa; Dopamine; Electrochemistry; Electrodes; Injections, Intravenous; Lethal Dose 50; Mice; No-Observed-Adverse-Effect Level; Osmolar Concentration; Oxidation-Reduction; Parkinson Disease; Spectrophotometry, Ultraviolet; Thiazines

1996